Research

Advances in Biology and the Web Are Radically Altering Cancer Trials

September 15, 2014

Amy Clark, Robert Vonderheide, Angela DeMichele and Martha Sweeney of the Perelman School of Medicine are quoted about new advances for cancer clinical trials.

Article Source: Philadelphia Inquirer
facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604September 15, 2014

Penn Center for Innovation’s Mobile App Challenge Is Back for a Second Year

blurb: 
Last fall, the Penn Center for Innovation launched the AppItUP Challenge, a contest that gathered mobile app ideas from across the University of Pennsylvania community and helped bring the best ones to life.

By Madeleine Stone @themadstone

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604September 15, 2014

Penn Team Studies Nanocrystals by Passing Them Through Tiny Pores

An interdisciplinary team of University of Pennsylvania researchers has now applied a cutting-edge technique for rapid gene sequencing toward measuring other nanoscopic structures. By passing nanoscale spheres and rods through a tiny hole in a membrane, the team was able to measure the electrical properties of those structures’ surfaces.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604September 14, 2014

Penn Research Helps Uncover Mechanism Behind Solid-Solid Phase Transitions

Two solids made of the same elements but with different geometric arrangements of the atoms, or crystal phases, can produce materials with different properties. Coal and diamond offer a spectacular example of this effect.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658September 11, 2014

Penn Medicine: Zebrafish Model of a Learning and Memory Disorder Shows Better Way to Target Treatment

Using a zebrafish model of a human genetic disease called neurofibromatosis (NF1), a team from the Perelman School of Medicine at the University of Pennsylvania has found that the learning and memory components of the disorder are distinct features that will likely need different treatment approaches.

facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937September 11, 2014

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.

facebook twitter google print email
Media Contact:Greg Richter | gregory.richter@uphs.upenn.edu | 215-614-1937September 11, 2014

Penn Medicine Study Reveals Profile of Patients Most Likely to Delay Hospice Enrollment Until Final Days of Life

One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658September 9, 2014

Penn Researcher and CVS Health Physician Urge New Payment Model for Costly Gene Therapy Treatments

Hoping to encourage sufficient investments by pharmaceutical companies in expensive gene therapies, which often consist of a single treatment, a Penn researcher and the chief medical officer of CVS Health outline an alternative payment model in this month’s issue of Nature Biotechnology.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658September 8, 2014

Penn Team Finds Ovarian Cancer Oncogene in 'Junk DNA'

Over the years researchers have made tremendous strides in the understanding and treatment of cancer by searching genomes for links between genetic alterations and disease.

Study of Jewish Women Shows Link to Cancer Without Family History

September 4, 2014

Susan Domchek of the Perelman School of Medicine says that the study does not “resolve the question of what the risk is to someone with no family history and a mutation.”

Article Source: New York Times